Kaisa Health Group Holdings Limited (stock code 00876) submitted its monthly return for the period ended 31 January 2026. According to the announcement, the total authorised share capital remained at HKD 200,000,000, comprising 160,000,000,000 ordinary shares at a par value of HKD 0.00125 each. The number of issued shares also remained unchanged at 5,042,139,374.

The public float requirement for the company’s ordinary shares was confirmed as satisfied. Regarding share options under the scheme adopted on 8 June 2015 with an exercise price of HKD 0.196, 62,000,000 share options remained outstanding with no new grants, exercises, cancellations, or lapses during the month. No warrants, convertibles, or other arrangements resulted in changes to the share capital, and no treasury shares were held or released. No new funds were raised during January 2026.